Summary

Synexa specializes in advanced diagnostic technology solutions through a diverse portfolio of expertise in biomarker identification, large and small molecule clinical bioanalysis, and soluble biomarker analysis. Their core capabilities include MS and LC-MSMS mass spectrometry to identify rare disease genes, as well as Immunoassay and ELISA technologies for analyzing antibodies, vaccines, and biomarkers. The company also offers Translational services utilizing Olink Proteomics, Genomics, Tissue Imaging, and Dose Formulation Analysis tools, providing end-to-end clinical trial support. Beyond specialized laboratory methods, Synexa emphasizes Quality Management Systems, environmental sustainability initiatives, and workforce development to serve as a comprehensive global provider for clinical research organizations.

Bioanalysis and Biomarker Services (1/2)

Advanced Molecular Technologies (2/2)

Clinical Support (3/3)

Quality Management (4/4)

Environmental Sustainability (5/5)

Title

Synexa Life Sciences: Global Scientific Excellence

Description

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

Keywords

services, https, expertise, consultation, service, analysis, flow, development, insights, assays, more, quality, life, sciences, management, mass, immunoassay

NS Lookup

A 209.38.44.40

Dates

Created 2026-04-14

Updated 2026-04-15

Summarized 2026-04-16